Bank of New York Mellon Corp Boosts Holdings in Omega Healthcare Investors, Inc. $OHI

Bank of New York Mellon Corp boosted its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 12.8% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 3,522,082 shares of the real estate investment trust’s stock after purchasing an additional 398,930 shares during the period. Bank of New York Mellon Corp’s holdings in Omega Healthcare Investors were worth $129,084,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in OHI. Farther Finance Advisors LLC lifted its holdings in Omega Healthcare Investors by 7.1% during the second quarter. Farther Finance Advisors LLC now owns 4,182 shares of the real estate investment trust’s stock valued at $153,000 after purchasing an additional 279 shares during the last quarter. United Services Automobile Association boosted its stake in Omega Healthcare Investors by 1.8% in the 1st quarter. United Services Automobile Association now owns 16,598 shares of the real estate investment trust’s stock worth $632,000 after purchasing an additional 291 shares during the period. CreativeOne Wealth LLC boosted its position in shares of Omega Healthcare Investors by 3.4% in the first quarter. CreativeOne Wealth LLC now owns 9,487 shares of the real estate investment trust’s stock valued at $361,000 after acquiring an additional 310 shares during the period. Maridea Wealth Management LLC grew its position in shares of Omega Healthcare Investors by 1.7% during the 2nd quarter. Maridea Wealth Management LLC now owns 19,146 shares of the real estate investment trust’s stock valued at $702,000 after purchasing an additional 329 shares in the last quarter. Finally, UniSuper Management Pty Ltd boosted its stake in Omega Healthcare Investors by 0.5% during the first quarter. UniSuper Management Pty Ltd now owns 76,200 shares of the real estate investment trust’s stock valued at $2,902,000 after buying an additional 400 shares during the period. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Stock Down 1.0%

Shares of Omega Healthcare Investors stock opened at $42.59 on Friday. The stock has a market capitalization of $12.56 billion, a PE ratio of 26.29, a price-to-earnings-growth ratio of 1.85 and a beta of 0.69. Omega Healthcare Investors, Inc. has a 52-week low of $35.04 and a 52-week high of $43.54. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. The company has a 50-day simple moving average of $41.50 and a two-hundred day simple moving average of $39.23.

Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.77 by $0.02. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business had revenue of $260.74 million during the quarter, compared to analyst estimates of $262.48 million. During the same quarter last year, the company earned $0.71 EPS. The company’s quarterly revenue was up 14.4% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. On average, analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Monday, November 3rd will be issued a $0.67 dividend. The ex-dividend date is Monday, November 3rd. This represents a $2.68 annualized dividend and a yield of 6.3%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 149.72%.

Insiders Place Their Bets

In other Omega Healthcare Investors news, CIO Vikas Gupta bought 11,500 shares of the business’s stock in a transaction that occurred on Thursday, November 6th. The stock was bought at an average cost of $42.97 per share, for a total transaction of $494,155.00. Following the completion of the transaction, the executive owned 13,773 shares of the company’s stock, valued at $591,825.81. This represents a 505.94% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO C Taylor Pickett acquired 20,000 shares of the business’s stock in a transaction dated Wednesday, November 5th. The shares were acquired at an average cost of $43.14 per share, with a total value of $862,800.00. Following the transaction, the chief executive officer owned 20,000 shares in the company, valued at approximately $862,800. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Company insiders own 1.50% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on OHI. Cantor Fitzgerald began coverage on shares of Omega Healthcare Investors in a research report on Wednesday, October 1st. They set an “overweight” rating and a $50.00 price objective on the stock. Mizuho boosted their price objective on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research report on Thursday, September 11th. Truist Financial increased their target price on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a report on Wednesday, September 3rd. Wells Fargo & Company raised their price target on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 21st. Finally, Royal Bank Of Canada lifted their price objective on Omega Healthcare Investors from $41.00 to $44.00 and gave the company a “sector perform” rating in a research report on Thursday. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Omega Healthcare Investors currently has an average rating of “Moderate Buy” and a consensus price target of $44.29.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.